VivoSim Labs, Inc. (VIVS)
0.281
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:37
VivoSim Labs Total Liabilities (Quarterly) : 6.193M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.193M |
| March 31, 2026 | 8.602M |
| December 31, 2025 | 2.519M |
| September 30, 2025 | 2.621M |
| June 30, 2025 | 2.44M |
| March 31, 2025 | 4.158M |
| December 31, 2024 | 3.48M |
| September 30, 2024 | 3.074M |
| June 30, 2024 | 2.808M |
| March 31, 2024 | 2.748M |
| December 31, 2023 | 2.699M |
| September 30, 2023 | 2.705M |
| June 30, 2023 | 2.98M |
| March 31, 2023 | 4.984M |
| December 31, 2022 | 2.79M |
| September 30, 2022 | 2.904M |
| June 30, 2022 | 2.892M |
| March 31, 2022 | 3.087M |
| December 31, 2021 | 3.802M |
| September 30, 2021 | 1.675M |
| June 30, 2021 | 0.964M |
| March 31, 2021 | 0.721M |
| December 31, 2020 | 0.829M |
| September 30, 2020 | 0.658M |
| June 30, 2020 | 0.835M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.81M |
| December 31, 2019 | 2.358M |
| September 30, 2019 | 6.698M |
| June 30, 2019 | 7.312M |
| March 31, 2019 | 4.325M |
| December 31, 2018 | 4.01M |
| September 30, 2018 | 3.755M |
| June 30, 2018 | 3.736M |
| March 31, 2018 | 5.241M |
| December 31, 2017 | 4.953M |
| September 30, 2017 | 4.853M |
| June 30, 2017 | 4.443M |
| March 31, 2017 | 6.818M |
| December 31, 2016 | 5.227M |
| September 30, 2016 | 5.049M |
| June 30, 2016 | 4.004M |
| March 31, 2016 | 5.395M |
| December 31, 2015 | 5.497M |
| September 30, 2015 | 5.525M |
| June 30, 2015 | 5.244M |
| March 31, 2015 | 4.793M |
| December 31, 2014 | 3.76M |
| September 30, 2014 | 3.114M |
| June 30, 2014 | 3.09M |
| March 31, 2014 | 1.902M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.847M |
| Shareholders Equity (Quarterly) | -2.346M |
| Debt to Equity Ratio | -0.1347 |
| Current Ratio | 1.704 |
| Net Debt Paydown Yield | 4.41% |